Mental Health DailyResearch. Evidence. Perspective.Published research on abilify.
Abilify (Aripiprazole) is a medication that was developed by Otsuka Pharmaceuticals and approved by the FDA in 2002 for the treatment of schizophrenia. Approximately 2 years thereafter (in 2…
Read articleAbilify (Aripiprazole) is an atypical antipsychotic drug that is commonly used to treat severe psychiatric conditions like schizophrenia and bipolar disorder. In recent years, it has been he…
Read articleAbilify (Aripiprazole) is an atypical antipsychotic medication that functions primarily to treat schizophrenia and bipolar disorder. It also has also been approved to help treat major depres…
Read articleResearch firm IMS Health has been collecting data on the number of prescriptions filled for certain drugs as well as the top selling drugs. The data that they collected was from July 2013 to…
Read articleA newly released report from research firm IMS Health collected data on the most prescribed drugs in the United States from June 2013 to July 2014. Although the number one drug was Synthroid…
Read articleAbilify (Aripiprazole) is an atypical antipsychotic medication that is used to treat schizophrenia, bipolar disorder, and in some cases is used as an “add on” treatment in severe depression.…
Read article